New research reveals that people who come off new slimming jabs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who stop traditional lifestyle plans.
Research printed in a major medical journal demonstrates that while obese people often shed about a fifth of their total mass while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing such drugs must be aware of the risk of quick rebound weight gain when the treatment ends," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a reversion to starting mass within about one and a half years.
Analyzing Treatments
The study, which looked at dozens of studies involving over 9,000 of patients, contrasted the effects of the injectable medications with older methods.
Researchers point out that individuals who lose weight through dieting typically experience a less rapid creep back—around 100 grams monthly—after stopping.
Understanding the Quick Rebound
Doctors suggest the way of the jabs explains the heightened weight return.
The injections mimic a natural hormone called glucagon-like peptide-1, which controls hunger.
"Artificially providing GLP-1 levels far above than the body's typical production may cause the body to generate a reduced amount of its own natural hormone, and could lessen sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this medication means appetite is uncontrolled, making binge eating far more likely."
An Ongoing Condition?
Medical guidelines advise the injections for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
Professionals contend that, given the significant potential of relapse, the treatment might need to be long-term.
This perspective is supported by drug manufacturers, who state that the findings "emphasize the long-term character of obesity," similar to managing diseases like diabetes.
User Testimonies
Individuals who have discontinued the medication report a powerful return of appetite.
"It was like a switch activating and you become ravenous," said an individual.
This challenge is worsened if patients have not established permanent lifestyle or habit modifications during treatment.
Significant Interest
Recent estimates show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.
- Use is more common among women compared to males.
- The middle-aged age group shows the highest level of interest.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, experts caution that while these medications are potent agents for weight loss, they are not a magic fix and long-term success relies on combined lifestyle changes.
